Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 41 results.
User Information
Export Records
  1. 1.   Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients
  2. Radtke, Andrea J; Postovalova, Ekaterina; Varlamova, Arina; Bagaev, Alexander; Sorokina, Maria; Kudryashova, Olga; Meerson, Mark; Polyakova, Margarita; Galkin, Ilia; Svekolkin, Viktor; Isaev, Sergey; Wiebe, Daniil; Sharun, Anna; Sarachakov, Alexander; Perelman, Grigory; Lozinsky, Yaroslav; Yaniv, Ziv; Lowekamp, Bradley C; Speranza, Emily; Yao, Li; Pittaluga, Stefania; Shaffer, Arthur L; Jonigk, Danny; Phelan, James D; Davies-Hill, Theresa; Huang, Da Wei; Ovcharov, Pavel; Nomie, Krystle; Nuzhdina, Ekaterina; Kotlov, Nikita; Ataullakhanov, Ravshan; Fowler, Nathan; Kelly,Michael; Muppidi, Jagan; Davis, Jeremy L; Hernandez, Jonathan M; Wilson, Wyndham H; Jaffe, Elaine S; Staudt, Louis M; Roschewski, Mark; Germain, Ronald N
  3. Cancer Cell. 2024, Feb 21; 42
  1. 2.   Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas
  2. Dersh, Devin; Phelan, James D; Gumina, Megan E; Wang, Boya; Arbuckle, Jesse H; Holly, Jaroslav; Kishton, Rigel J; Markowitz,Tovah; Seedhom, Mina O; Fridlyand, Nathan; Wright, George W; Huang, Da Wei; Ceribelli, Michele; Thomas, Craig J; Lack,Justin; Restifo, Nicholas P; Kristie, Thomas M; Staudt, Louis M; Yewdell, Jonathan W
  3. Immunity. 2021, Jan 12; 54(1): 116-131.e10.
  1. 3.   Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes
  2. Moore, Amy; Machiela, Mitchell J; Machado, Moara; Wang, Sophia S; Kane, Eleanor; Slager, Susan L; Zhou, Weiyin; Carrington,Mary; Lan, Qing; Milne, Roger L; Birmann, Brenda M; Adami, Hans-Olov; Albanes, Demetrius; Arslan, Alan A; Becker, Nikolaus; Benavente, Yolanda; Bisanzi, Simonetta; Boffetta, Paolo; Bracci, Paige M; Brennan, Paul; Brooks-Wilson, Angela R; Canzian, Federico; Caporaso, Neil; Clavel, Jacqueline; Cocco, Pierluigi; Conde, Lucia; Cox, David G; Cozen, Wendy; Curtin, Karen; De Vivo, Immaculata; de Sanjose, Silvia; Foretova, Lenka; Gapstur, Susan M; Ghesquières, Hervè; Giles, Graham G; Glenn, Martha; Glimelius, Bengt; Gao, Chi; Habermann, Thomas M; Hjalgrim, Henrik; Jackson, Rebecca D; Liebow, Mark; Link, Brian K; Maynadie, Marc; McKay, James; Melbye, Mads; Miligi, Lucia; Molina, Thierry J; Monnereau, Alain; Nieters, Alexandra; North, Kari E; Offit, Kenneth; Patel, Alpa V; Piro, Sara; Ravichandran, Vignesh; Riboli, Elio; Salles, Gilles; Severson, Richard K; Skibola, Christine F; Smedby, Karin E; Southey, Melissa C; Spinelli, John J; Staines, Anthony; Stewart, Carolyn; Teras, Lauren R; Tinker, Lesley F; Travis, Ruth C; Vajdic, Claire M; Vermeulen, Roel C H; Vijai, Joseph; Weiderpass, Elisabete; Weinstein, Stephanie; Doo, Nicole Wong; Zhang, Yawei; Zheng, Tongzhang; Chanock, Stephen J; Rothman, Nathaniel; Cerhan, James R; Dean,Michael; Camp, Nicola J; Yeager,Meredith; Berndt, Sonja I
  3. Journal of translational genetics and genomics. 2021 5: 200-217.
  1. 4.   NK cells prevent T cell lymphoma development in T cell receptor-transgenic mice
  2. Dubois, Sigrid; Feigenbaum, Lionel; Waldmann, Thomas A; Müller, Jürgen R
  3. Cellular immunology. 2020, JUN; 352: 104081.
  1. 5.   Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study
  2. Khodadoust, Michael S; Rook, Alain H; Porcu, Pierluigi; Foss, Francine; Moskowitz, Alison J; Shustov, Andrei; Shanbhag, Satish; Sokol, Lubomir; Fling, Steven P; Ramchurren, Nirasha; Pierce, Robert; Davis, Asa; Shine, Richard; Li, Shufeng; Fong, Sophia; Kim, Jinah; Yang, Yi; Blumenschein, Wendy M; Yearley, Jennifer H; Das,Biswajit; Patidar,Rajesh; Datta, Vivekananda; Cantu,Erin; McCutcheon,Justine; Karlovich,Chris; Williams,Mickey; Subrahmanyam, Priyanka B; Maecker, Holden T; Horwitz, Steven M; Sharon, Elad; Kohrt, Holbrook E; Cheever, Martin A; Kim, Youn H
  3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020, JAN 1; 38(1): 20-+.
  1. 6.   Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenstrom macroglobulinemia
  2. McMaster, Mary L.; Berndt, Sonja; Zhang, Jianqing; Slager, Susan L.; Li,Shengchao; Vajdic, Claire M.; Smedby, Karin E.; Yan, Huihuang; Birmann, Brenda M.; Brown, Elizabeth E.; Smith, Alex; Kleinstern, Geffen; Fansler, Mervin M.; Mayr, Christine; Zhu,Bin; Chung,Charles; Park, Ju-Hyun; Burdette, Laurie; Hicks,Belynda; Hutchinson,Amy; Teras, Lauren R.; Adami, Hans-Olov; Bracci, Paige M.; McKay, James; Monnereau, Alain; Link, Brian K.; Vermeulen, Roel C. H.; Ansell, Stephen M.; Maria, Ann; Diver, W. Ryan; Melbye, Mads; Ojesina, Akinyemi; Kraft, Peter; Boffetta, Paolo; Clavel, Jacqueline; Giovannucci, Edward; Besson, Caroline M.; Canzia, Federico; Travis, Ruth C.; Vineis, Paolo; Weiderpass, Elisabete; Montalvan, Rebecca; Wang, Zhaoming; Yeager,Meredith; Becker, Nikolaus; Benavente, Yolanda; Brennan, Paul; Foretova, Lenka; Maynadie, Marc; Nieters, Alexandra; de Sanjose, Silvia; Staines, Anthony; Conde, Lucia; Riby, Jacques; Glimelius, Bengt; Hjalgrim, Henrik; Pradhan, Nisha; Feldman, Andrew L.; Novak, Anne J.; Lawrence, Charles; Bassig, Bryan A.; Lan, Qing; Zheng, Tongzhang; North, Kari E.; Tinker, Lesley F.; Cozen, Wendy; Severson, Richard K.; Hofmann, Jonathan N.; Zhang, Yawei; Jackson, Rebecca D.; Morton, Lindsay M.; Purdue, Mark P.; Chatterjee, Nilanjan; Offit, Kenneth; Cerhan, James R.; Chanock, Stephen J.; Rothman, Nathaniel; Vijai, Joseph; Goldin, Lynn R.; Skibola, Christine F.; Caporaso, Neil E.
  3. NATURE COMMUNICATIONS. 2018, OCT 10; 9(1): 4182.
  1. 7.   Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma
  2. Lu, Li; Zhu, Fen; Zhang, Meili; Li, Yangguang; Drennan, Amanda C; Kimpara, Shuichi; Rumball, Ian; Selzer, Christopher; Cameron, Hunter; Kellicut, Ashley; Kelm, Amanda; Wang, Fangyu; Waldmann, Thomas A; Rui, Lixin
  3. Proceedings of the National Academy of Sciences of the United States of America. 2018, Jan 16; 115(3): E498-E505.
  1. 8.   Prediagnostic Serum Levels of Cytokines and Other Immune Markers and Risk of Non-Hodgkin Lymphoma
  2. Purdue, M. P.; Lan, Q.; Bagni, R.; Hocking, W. G.; Baris, D.; Reding, D. J.; Rothman, N.
  3. Cancer Research. 2011, Jul; 71(14): 4898-4907.
  1. 9.   Impact of ABCB1 Allelic Variants on QTc Interval Prolongation
  2. Sissung, T. M.; Gardner, E. R.; Piekarz, R. L.; Howden, R.; Chen, X. H.; Woo, S.; Franke, R.; Clark, J. A.; Miller-DeGraff, L.; Steinberg, S. M.; Venzon, D.; Liewehr, D.; Kleeberger, S. R.; Bates, S. E.; Price, D. K.; Rosing, D. R.; Cabell, C.; Sparreboom, A.; Figg, W. D.
  3. Clinical Cancer Research. 2011, Feb; 17(4): 937-946.
  1. 10.   A novel role for IL-22R1 as a driver of inflammation
  2. Savan, R.; McFarl, A. P.; Reynolds, D. A.; Feigenbaum, L.; Ramakrishnan, K.; Karwan, M.; Shirota, H.; Klinman, D. M.; Dunleavy, K.; Pittaluga, S.; Anderson, S. K.; Donnelly, R. P.; Wilson, W. H.; Young, H. A.
  3. Blood. 2011, Jan; 117(2): 575-584.
  1. 11.   A Novel Method of Amplification of FFPET-Derived RNA Enables Accurate Disease Classification with Microarrays
  2. Williams, P. M.; Li, R.; Johnson, N. A.; Wright, G.; Heath, J. D.; Gascoyne, R. D.
  3. Journal of Molecular Diagnostics. 2010, Sep; 12(5): 680-686.
  1. 12.   Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv
  2. Loomis, K.; Smith, B.; Feng, Y.; Garg, H.; Yavlovich, A.; Campbell-Massa, R.; Dimitrov, D. S.; Blumenthal, R.; Xiao, X. D.; Puri, A.
  3. Experimental and Molecular Pathology. 2010, Apr; 88(2): 238-249.
  1. 13.   Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
  2. Bates, S. E.; Zhan, Z. R.; Steadman, K.; Obrzut, T.; Luchenko, V.; Frye, R.; Robey, R. W.; Turner, M.; Gardner, E. R.; Figg, W. D.; Steinberg, S. M.; Ling, A.; Fojo, T.; To, K. W.; Piekarz, R. L.
  3. British Journal of Haematology. 2010, Jan; 148(2): 256-267.
  1. 14.   Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
  2. Puri, A.; Loomis, K.; Smith, B.; Lee, J. H.; Yavlovich, A.; Heldman, E.; Blumenthal, R.
  3. Critical Reviews in Therapeutic Drug Carrier Systems. 2009 26(6): 523-580.
  1. 15.   A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma
  2. Purdue, M. P.; Lan, Q.; Martinez-Maza, O.; Oken, M. M.; Hocking, W.; Huang, W. Y.; Baris, D.; Conde, B.; Rothman, N.
  3. Blood. 2009 114(13): 2730-2732.
  1. 16.   A novel proteoliposomal vaccine induces antitumor immunity against follicular lymphoma
  2. Neelapu, S. S.; Gause, B. L.; Harvey, L.; Lee, S. T.; Frye, A. R.; Horton, J.; Robb, R. J.; Popescu, M. C.; Kwak, L. W.
  3. Blood. 2007, Jun; 109(12): 5160-5163.
  1. 17.   Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1
  2. Zhang, M. L.; Yao, Z. S.; Patel, H.; Garmestani, K.; Zhang, Z.; Talanov, V. S.; Plascjak, P. S.; Goldman, C. K.; Janik, J. E.; Brechbiel, M. W.; Waldmann, T. A.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, May; 104(20): 8444-8448.
  1. 18.   Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study
  2. Purdue, M. P.; Lan, Q.; Kricker, A.; Grulich, A. E.; Vajdic, C. M.; Turner, J.; Whitby, D.; Chanock, S.; Rothman, N.; Armstrong, B. K.
  3. Carcinogenesis. 2007, Mar; 28(3): 704-712.
  1. 19.   MicroRNAs and genomic instability
  2. Huppi, K.; Volfovsky, N.; Mackiewicz, M.; Runfola, T.; Jones, T. L.; Martin, S. E.; Stephens, R.; Caplen, N. J.
  3. Seminars in Cancer Biology. 2007, Feb; 17(1): 65-73.
  1. 20.   Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis
  2. Timofeeva, O. A.; Plisov, S.; Evseev, A. A.; Peng, S.; Jose-Kampfner, M.; Lovvorn, H. N.; Dome, J. S.; Perantoni, A. O.
  3. Oncogene. 2006, Dec; 25(58): 7555-7564.
  1. 21.   Hepatitis C and risk of lymphoma: Results of the European Multicenter Case-Control Study EPILYMPH
  2. Nieters, A.; Kallinowski, B.; Brennan, P.; Ott, M.; Maynadie, M.; Benavente, Y.; Foretova, L.; Cocco, P. L.; Staines, A.; Vornanen, M.; Whitby, D.; Boffetta, P.; Becker, N.; De Sanjose, S.
  3. Gastroenterology. 2006, Dec; 131(6): 1879-1886.
  1. 22.   The novel DNA methylation inhibitor zebularine is effective against the development of murine T-cell lymphoma
  2. Herranz, M.; Martin-Caballero, J.; Fraga, M. F.; Ruiz-Cabello, J.; Flores, J. M.; Desco, M.; Marquez, V.; Esteller, M.
  3. Blood. 2006, FEB 1; 107(3): 1174-1177.
  1. 23.   Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium
  2. Rothman, N.; Skibola, C. F.; Wang, S. S.; Morgan, G.; Lon, Q.; Smith, M. T.; Spinelli, J. J.; Willett, E.; De Sanjose, S.; Cocco, P.; Berndt, S. I.; Brennan, P.; Brooks-Wilson, A.; Wacholder, S.; Becker, N.; Hartge, P.; Zheng, T. Z.; Roman, E.; Holly, E. A.; Boffetta, P.; Armstrong, B.; Cozen, W.; Linet, M.; Bosch, F. X.; Ennas, M. G.; Holford, T. R.; Gallagher, R. P.; Rollinson, S.; Bracci, P. M.; Cerhan, J. R.; Whitby, D.; Moore, P. S.; Leaderer, B.; Lai, A.; Spink, C.; Davis, S.; Bosch, R.; Scarpa, A.; Zhang, Y. W.; Severson, R. K.; Yeager, M.; Chanock, S.; Nieters, A.
  3. Lancet Oncology. 2006, JAN; 7(1): 27-38.
  1. 24.   Gadd45a acts as a modifier locus for lymphoblastic lymphoma
  2. Hollander, M. C.; Patterson, A. D.; Salvador, J. M.; Anver, M. R.; Hunger, S. P.; Fornace, A. J.
  3. Leukemia. 2005, MAY; 19(5): 847-850.
  1. 25.   Targeting malignant B-cell lymphoma with a humanized anti-CD22 scFv-angiogenin immunoenzyme
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Rybak, S. M.
  3. British Journal of Haematology. 2005, MAR; 128(5): 602-609.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel